The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia

Risk factors for relapse and non-relapse mortality (NRM) in the first years after allogeneic hematopoietic stem cells transplant (allo-HSCT) for acute myeloid leukemia (AML) are well known, but their correlation with long-term survivorship is unclear. This study aims to evaluate factors that impact...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Alessandro Bruno, Francesca Lorentino, Matteo G. Carrabba, Sara Mastaglio, Raffaella Greco, Sarah Marktel, Simona Piemontese, Magda Marcatti, Luca Vago, Francesca Farina, Daniela Clerici, Elisa Diral, Lorenzo Lazzari, Edoardo Campodonico, Daniele Sannipoli, Andrea Assanelli, Consuelo Corti, Massimo Bernardi, Jacopo Peccatori, Fabio Ciceri, Maria Teresa Lupo-Stanghellini
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2026-05-01
Serier:	Frontiers in Immunology
Fag:	allogeneic stem cell transplantation (allo-SCT) AML - acute myeloid leukemia disease status at transplantation long term survivorship overall survival
Online adgang:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1818603/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!